|
Recorded Presentation from Optimizing Patient Outcomes - The Role of Immunotherapy and Emerging Strategies for High-Risk Neuroblastoma |
1.00 |
11/05/2025 - 12:00am to 10/29/2026 - 11:59pm |
|
NCCN Guidelines® Insights - Breast Cancer, Version 5.2025 |
1.00 |
11/10/2025 - 12:00am to 11/10/2026 - 11:59pm |
|
Optimizing Cytoreductive Therapy for Polycythemia Vera |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Recorded Presentations from the NCCN 2025 Annual Congress: Hematologic Malignancies™ |
|
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Management of High-Risk Acute Promyelocytic Leukemia in the Community Setting |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Fertility Preservation in Hematologic Malignancies: Navigating Complex Choices |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Evolving Treatment Options for Low-Risk Myelodysplastic Syndromes |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Diagnosis and Management of Secondary Hemophagocytic Lymphohistiocytosis |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Novel Treatment Options for Hodgkin Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Optimizing First-Line Therapy for Diffuse Large B-Cell Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Emerging Treatment Options for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
0.75 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Deploying Novel Therapies for Acute Lymphoblastic Leukemia |
1.00 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Integrating New Therapies for the Treatment of Chronic Phase Chronic Myeloid Leukemia |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
|
Role of Allogeneic Transplants in Acute Lymphoblastic Leukemia |
0.50 |
12/01/2025 - 12:00am to 11/30/2026 - 11:59pm |
Facebook
X
LinkedIn
Forward